Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial

Bibliographic Details
Title: Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
Authors: Borg, Christophe, Etienne, Pierre-Luc, Rio, Emmanuel, Mesgouez-Nebout, Nathalie, François, Éric, Vendrely, Véronique, Conroy, Thierry, Artignan, Xavier, Bouché, Olivier, Gargot, Dany, Boige, Valérie, Bonichon-Lamichhane, Nathalie, Louvet, Christophe, Morand, Clotilde, de la Fouchardière, Christelle, Ronchin, Philippe, Seitz, Jean-François, Corbinais, Stéphane, Maillard, Emmanuel, Noirclerc, Monique, El Hajbi, Farid, Villing, Anne-Laure, Bécouarn, Yves, Foong Fat Lam Kam Sang, Lam, Artru, Pascal, Bachet, Jean-Baptiste, Hocine, Fayçal, Ligeza-Poisson, Catherine, Vautravers, Claire, Ben Abdelghani, Meher, Aparicio, Thomas, Desot, Elise, Marquis, Isabelle, Bosset, Jean-François, Lamfichekh, Najib, Juzyna, Béata, Jouffroy-Zeller, Claire, Rullier, Eric, Marchal, Frédéric, Gourgou, Sophie, Castan, Florence
Source: In The Lancet Oncology May 2021 22(5):702-715
Database: ScienceDirect
More Details
ISSN:14702045
DOI:10.1016/S1470-2045(21)00079-6
Published in:The Lancet Oncology
Language:English